Results 191 to 196 of about 6,571 (196)

Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer

Cancer Letters
Guangwei Zhu, Lin Chunlin, Hengxin Yao
exaly  

YBX1 as a prognostic biomarker and potential therapeutic target in hepatocellular carcinoma: A comprehensive investigation through bioinformatics analysis and in vitro study

Translational Oncology
Amin Huang, Wenhua Lu, Feng Yin
exaly  

O-GlcNAcylation of YBX1 drives a glycolysis-histone lactylation feedback loop in hepatocellular carcinoma

Cancer Letters
Tianyu Huang
exaly  

YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer

Cancer Letters
Borui Li, Jingyi Wang, Fan Guixiong
exaly  

Exploration of YBX1 role in the prognostic value and immune characteristics by single-cell and bulk sequencing analysis for liver hepatocellular carcinoma

Journal of Gene Medicine
Lungen Lu, Bingye Zhu, Qidi Zhang
exaly  

839 The role of YBX1 in prostate cancer – results from a 180K custom agilent microarray position YBX1 as a possible master regulator in prostate cancer

European Urology Supplements, 2014
openaire   +1 more source